The proteomic analysis of human neonatal umbilical cord serum by mass spectrometry

Acta Pharmacologica Sinica

Volumn 30, Issue 11, 2009, Pages 1550-1558

  Song, Hong Juan ^a,c   Zhang, Ping ^b   Guo, Xue Jiang ^b   Liao, Lian Ming ^c   Zhou, Zuo Min ^b   Sha, Jia Hao ^b   Cui, Yu Gui ^c   Ji, Hui ^a   Liu, Jia Yin ^a,c  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Department of Neurosurgery   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Mass spectrometry; Reference specimen; Serum proteome; Umbilical cord serum

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1; ALPHA 2 MACROGLOBULIN; ALPHA FETOPROTEIN; ALPHA LEVO FUCOSIDASE; APOLIPOPROTEIN B100; AUTOTAXIN; BINDING PROTEIN; COLLAGEN DERIVATIVE; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT RECEPTOR; CYTOKERATIN 6; ENDOTHELIAL PROTEIN C RECEPTOR; FIBRINOGEN; FIBRONECTIN; FUMARYLACETOACETASE; GUANINE NUCLEOTIDE BINDING PROTEIN; INTER ALPHA TRYPSIN INHIBITOR; LYSOZYME; MALATE DEHYDROGENASE; PEROXIREDOXIN 6; PROTEASOME; PROTEIN PRECURSOR; PROTEOME; PROTHROMBIN; RAN PROTEIN; TENASCIN; TRANSCRIPTION FACTOR RUNX2; TRANSFERRIN; TRANSGELIN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FUNCTIONAL PROTEOMICS; HUMAN; MALE; NEWBORN; PEPTIDE ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN LOCALIZATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; SEX DIFFERENCE; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

ADULT; BIOLOGICAL MARKERS; BLOOD PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PROTEOMICS; SEX CHARACTERISTICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; YOUNG ADULT;

EID: 70449353726     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.140     Document Type: Article

References (28)

1. Adkins JN, Varnum SM, Auberry KJ, Moore RJ, Angell NH, Smith RD, et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 2002; 1: 947-955
2. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002; 1: 845-867
3. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 572-577
4. Pieper R, Gatlin CL, Makusky AJ, Russo PS, Schatz CR, Miller SS, et al. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 2003; 3: 1345-1364
5. Aivado M, Spentzos D, Germing U, Alterovitz G, Meng XY, Grall F, et al. Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease. Proc Natl Acad Sci USA 2007; 104: 1307-1312
6. He P, He HZ, Dai J, Wang Y, Sheng QH, Zhou LP, et al. The human plasma proteome: analysis of Chinese serum using shotgun strategy. Proteomics 2005; 5: 3442-3453
7. Vuadens F, Benay C, Crettaz D, Gallot D, Sapin V, Schneider P, et al. Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach. Proteomics 2003; 3: 1521-1525
8. Karamessinis PM, Malamitsi-Puchner A, Boutsikou T, Makridakis M, Vougas K, Fountoulakis M, et al. Marked defects in the expression and glycosylation of alpha2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and potential clinical implications. Mol Cell Proteomics 2008; 7: 591-599
9. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68: 850-858
10. Yates JR 3rd, Eng JK, McCormack AL, Schieltz D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 1995; 67: 1426-1436
11. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003; 75: 4646-4658
12. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: database for annotation, visualization, and integrateddiscovery. Genome Biol 2003; 4: P3.
13. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002; 74: 5383-5392
14. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008; 36: D480-4.
15. Tsangaris GT, Karamessinis P, Kolialexi A, Garbis SD, Antsaklis A, Mavrou A, et al. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics 2006; 6: 4410-4419
16. Van Hoof D, Passier R, Ward-Van Oostwaard D, Pinkse MW, Heck AJ, Mummery CL, et al. A quest for human and mouse embryonic stem cell-specific proteins. Mol Cell Proteomics 2006; 5: 1261-1273
17. Stubbs TM, Lazarchick J, Horger EO 3rd. Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. Am J Obstet Gynecol 1984; 150: 885-887
18. Gao M, Nakabayashi M, Sakura M, Takeda Y. The imbalance of plasminogen activators and inhibitor in preeclampsia. J Obstet Gynaecol Res 1996; 22: 9-16.
19. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265: 621-636
20. Bowman BH, Kurosky A. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Adv Hum Genet 1982; 12: 189-261, 453-454
21. Okazaki T, Nagai T. Difference in hemoglobin-binding ability of polymers among haptoglobin phenotypes. Clin Chem 1997; 43: 2012-2013
22. Langlois MR, Delanghe JR, De Buyzere ML, Bernard DR, Ouyang J. Effect of haptoglobin on the metabolism of vitamin C. Am J Clin Nutr 1997; 66: 606-610
23. Melamed-Frank M, Lache O, Enav BI, Szafranek T, Levy NS, Ricklis RM, et al. Structure-function analysis of the antioxidant properties of haptoglobin. Blood 2001; 98: 3693-3698
24. Bernard D, Christophe A, Delanghe J, Langlois M, De Buyzere M, Comhaire F. The effect of supplementation with an antioxidant preparation on LDL-oxidation is determined by haptoglobin polymorphism. Redox Rep 2003; 8: 41-46
25. Delanghe J, Cambier B, Langlois M, De Buyzere M, Neels H, De Bacquer D, et al. Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery. Atherosclerosis 1997; 132: 215-219
26. Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 1999; 14: 1239-1249
27. Litvin J, Selim AH, Montgomery MO, Lehmann K, Rico MC, Devlin H, et al. Expression and function of periostin-isoforms in bone. J Cell Biochem 2004; 92: 1044-1061
28. Kudo Y, Siriwardena BS, Hatano H, Ogawa I, Takata T. Periostin: novel diagnostic and therapeutic target for cancer. Histol Histopathol 2007; 22: 1167-1174